MoneyWorks4Me

Emmessar Biotech&Nut - Quaterly Results

24 Apr 2025 Evaluate
The Sales for the quarter ended March 2025 of Rs. 0.96 millions rose by 28.00% from Rs. 0.75 millions.The Net Loss for the quarter ended March 2025 is Rs. -0.67 millions as compared to Net Profit of Rs. 2.70 millions of corresponding quarter ended March 2024Operating profit surged to 2.85 millions from the corresponding previous quarter of 0.91 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 0.96 0.75 28.00 6.11 5.55 10.09 6.11 5.55 10.09
Other Income 6.08 4.84 25.62 20.09 19.92 0.85 20.09 19.92 0.85
PBIDT 2.85 0.91 213.19 10.58 9.10 16.26 10.58 9.10 16.26
Interest 0.01 0.00 0.00 0.01 0.00 0.00 0.01 0.00 0.00
PBDT 2.84 0.91 212.09 10.57 9.10 16.15 10.57 9.10 16.15
Depreciation 0.24 0.24 0.00 0.98 0.98 0.00 0.98 0.98 0.00
PBT 2.60 0.67 288.06 9.59 8.12 18.10 9.59 8.12 18.10
TAX 3.27 -2.03 -261.08 6.42 1.62 296.30 6.42 1.62 296.30
Deferred Tax -0.08 0.00 0.00 2.02 1.49 35.57 2.02 1.49 35.57
PAT -0.67 2.70 -124.81 3.17 6.50 -51.23 3.17 6.50 -51.23
Equity 49.96 49.96 0.00 49.96 49.96 0.00 49.96 49.96 0.00
PBIDTM(%) 296.88 121.33 144.68 173.16 163.96 5.61 173.16 163.96 5.61
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..